Viewing Study NCT00946751


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-03-13 @ 10:42 AM
Study NCT ID: NCT00946751
Status: COMPLETED
Last Update Posted: 2017-03-28
First Post: 2009-07-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions
Sponsor: Sandoz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module